Next-Generation Sequencing for Congenital Nephrotic Syndrome: A Multi-Center Cross-Sectional Study from India.


Journal

Indian pediatrics
ISSN: 0974-7559
Titre abrégé: Indian Pediatr
Pays: India
ID NLM: 2985062R

Informations de publication

Date de publication:
15 May 2021
Historique:
entrez: 13 5 2021
pubmed: 14 5 2021
medline: 7 9 2021
Statut: ppublish

Résumé

Information on etiology of congenital nephrotic syndrome in non-Caucasian populations is limited. This study aimed to determine the genetic basis of congenital nephrotic syndrome in Indian patients. In this observational, cross-sectional study, whole exome sequencing was performed on samples from all children diagnosed with congenital nephrotic syndrome, presenting at centers collaborating in a nationwide registry and biorepository. Analysis was targeted to focus on reported or novel, pathogenic or likely pathogenic variants in 89 genes implicated in etiology of nephrotic syndrome. Sanger sequencing was used to confirm disease-causing variants in patients and allelic segregation of compound heterozygous variants in samples from parents. Inheritance of a shared haplotype was analyzed among ten individuals carrying the most common variant. During 2017-2019, 34 patients with congenital nephrotic syndrome were screened. Consanguinity and similar illness in siblings were reported in eleven patients each. Homozygous or compound heterozygous, pathogenic or likely pathogenic variants were found in NPHS1 in 24 cases, including two novel variants. One patient each had homozygous pathogenic or likely pathogenic known or novel variant in NPHS2, PLCE1, OSGEP and LAMB2 genes. Patients with OSGEP and LAMB2 mutations had phenotype typical of Galloway Mowat and Pierson syndromes, respectively. Three variants in NPHS1 were common to 16 individuals. One reported variant in exon 19 (c.2600G>A; p.Gly867Asp) appears to share a common founder. A genetic cause was determined for 82.4% patients with congenital nephrotic syndrome. Variants in NPHS1 are most common in Indian patients and founder mutations might be present.

Identifiants

pubmed: 33980730

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
Membrane Proteins 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-451

Auteurs

Aditi Joshi (A)

Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India.

Aditi Sinha (A)

Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Aakanksha Sharma (A)

Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Uzma Shamim (U)

Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India.

Bharathram Uppilli (B)

Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India.

Pooja Sharma (P)

Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India.

Sana Zahra (S)

Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India.

Shaista Parveen (S)

Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India.

Aradhana Mathur (A)

Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India.

Monica Chandan (M)

Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Prachi Tewari (P)

Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Priyanka Khandelwal (P)

Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Pankaj Hari (P)

Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Mitali Mukerji (M)

Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India.

Mohammed Faruq (M)

Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India. Dr Mohammed Faruq, Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India. faruq.mohd@igib.in.

Arvind Bagga (A)

Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. Correspondence to: Professor Arvind Bagga, Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. arvindbagga@hotmail.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH